Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Gains from Investment Securities (2017 - 2025)

Historic Gains from Investment Securities for Marimed (MRMD) over the last 11 years, with Q3 2025 value amounting to -$198000.0.

  • Marimed's Gains from Investment Securities fell 10418.16% to -$198000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 1891.89%. This contributed to the annual value of $2.9 million for FY2024, which is 5511.76% down from last year.
  • As of Q3 2025, Marimed's Gains from Investment Securities stood at -$198000.0, which was down 10418.16% from $363000.0 recorded in Q2 2025.
  • In the past 5 years, Marimed's Gains from Investment Securities ranged from a high of $10.9 million in Q2 2022 and a low of -$2.4 million during Q2 2024
  • Moreover, its 5-year median value for Gains from Investment Securities was $558000.0 (2023), whereas its average is $1.5 million.
  • As far as peak fluctuations go, Marimed's Gains from Investment Securities soared by 637760.23% in 2021, and later plummeted by 36010.7% in 2024.
  • Over the past 5 years, Marimed's Gains from Investment Securities (Quarter) stood at $202000.0 in 2021, then skyrocketed by 882.67% to $2.0 million in 2022, then plummeted by 124.43% to -$485000.0 in 2023, then surged by 113.4% to $65000.0 in 2024, then plummeted by 404.62% to -$198000.0 in 2025.
  • Its Gains from Investment Securities stands at -$198000.0 for Q3 2025, versus $363000.0 for Q2 2025 and $2.5 million for Q1 2025.